http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e269d10d89a38d6dccfe85fb861c8c65
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Auerbach |
| name | Bruce Auerbach |
| given-name | Bruce |
| organization-name | Office of Technology Transfer University of Michigan Ann Arbor Michigan USA From the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD (R.D.S., A.M.S., L.A.F., M.J.A., A.W., A.T.R.); AlphaCore Pharma LLC., Ann Arbor, MI (R.B.-A., B.A., B.R.K., R.H.); VascularStrategies LLC., Plymouth Meeting, PA (S.J.A., H.L.C.); and Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD (M.S.). the Department of Atherosclerosis Therapeutics (J.A.C., K.W., B.A.), Parke-Davis Pharmaceutical Research Division, Warner Lambert Co, Ann Arbor, MI; the Department of Pharmacology (S.J.F.), College of Physicians and Surgeons, Columbia University, New York, NY; and the Cardiovascular Division (A.D.), Department of Medicine, Washington University School of Medicine, St. Louis, Mo. Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, Michigan 48105 |
Incoming Links
Total number of triples: 20.